Tocilizumab: a review of its safety and efficacy in rheumatoid arthritis
{{output}}
Recent years have seen many exciting developments in the treatment of rheumatoid arthritis. Tocilizumab (TCZ) is a monoclonal antibody which inhibits the interleukin-6 receptor. After initial studies in Japan, it has been extensively studied in five multicentr... ...
